The transcription factor sex-determining region Y-related high-mobility group-box gene 9 (SOX9) plays a critical role in organ development.
Novo further boosts evidence for semaglutide’s heart benefits beyond weight loss: #ACC24
Novo Nordisk’s semaglutide has hit a pair of primary endpoints in a late-stage test in patients with a trio of cardiometabolic conditions, bolstering the company’s